These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4028200)

  • 21. [Effect of mexiletine on the excitability and vulnerability of the dog ventricle (author's transl)].
    Márquez Montes J; Vera Almazán A; Esteve Alderete JJ; Puente Rodero B; Montero C; Castillo-Olivares JL
    Arch Farmacol Toxicol; 1981 Dec; 7(3):307-18. PubMed ID: 7337470
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
    Noguchi Y; Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cellular mechanism of the antiarrhythmic action of propranolol].
    Kwiatkowska B; Czarnecka M; Lewartowski B
    Acta Physiol Pol; 1970; 21(4):441-54. PubMed ID: 5452921
    [No Abstract]   [Full Text] [Related]  

  • 24. Local anaesthetic and myocardial depressant effects of beta adrenoceptor blocking agents.
    Singh KP
    Indian J Physiol Pharmacol; 1980; 24(2):161-2. PubMed ID: 6103869
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
    Watanabe Y; Dreifus LS
    J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug information: agents for the treatment of cardiac arrhythmias. 5. (2) Arrhythmias relieved by changed impulse conduction/changed cellular reaction pattern].
    Lumholtz IB
    Sygeplejersken; 1980 Jul; 80(30):15. PubMed ID: 6905368
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of changrolin on electrophysiological properties of canine Purkinje fibers].
    Gu PK; Wang BY; Chen YL; Shang M; Liu XJ; Jin ZJ
    Zhongguo Yao Li Xue Bao; 1983 Sep; 4(3):170-2. PubMed ID: 6228115
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of amphotericin B on ECG in dogs].
    Dumova AM; Mushkin MV
    Antibiotiki; 1970 Jan; 15(1):76-81. PubMed ID: 5442477
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-arrhythmic drugs and heart conduction].
    Furlanello F
    G Clin Med; 1973 Jul; 54(7):382-406. PubMed ID: 4779853
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Effects of reperfusion on antiarrhythmic drug activity.
    Ecanow B; Gold BH
    N Engl J Med; 1976 Aug; 295(8):447-8. PubMed ID: 934247
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of antiarrhythmic drugs on the A-V conduction in isolated hearts.
    Brusca A; Rosettani E; Favella L
    G Ital Cardiol; 1972; 2(1):158. PubMed ID: 5011998
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: Review of the cardiovascular pharmacology of perhexiline.
    Hudak WJ; Lewis RE; Lucas RW; Kuhn WL
    Postgrad Med J; 1973 Apr; 49():Suppl 3:16-25. PubMed ID: 4202743
    [No Abstract]   [Full Text] [Related]  

  • 34. Myocardium stabilization by diphenylhydantoin.
    Wax SD; Webb WR; Ecker RR
    Surg Forum; 1969; 20():164-6. PubMed ID: 4192209
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of flecainide on longitudinal and transverse conduction velocities in ventricular myocardium. An experimental study].
    Ferrero A; Chorro FJ; Cánoves J; Mainar L; Blasco E; Such L
    Rev Esp Cardiol; 2007 Mar; 60(3):315-8. PubMed ID: 17394879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Electrical properties of a new beta-blocker agent, tertatolol, in man].
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Therapie; 1983; 38(4):371-8. PubMed ID: 6139893
    [No Abstract]   [Full Text] [Related]  

  • 37. Proceedings: Comparison of the effects of mexiletine, lignocaine and procainamide on canine Purkinje fibres.
    Allen JD; Arnold JM
    J Physiol; 1974 Jan; 236(1):26P-28P. PubMed ID: 4818502
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antifibrillatory and cardiovascular effects of VULM 456, a quaternary salt of exaprolol, on anesthetized dogs].
    Jezek L; Kochman J; Mahrla Z; Gasparík J; Spevák R
    Cesk Fysiol; 1988; 37(6):521-4. PubMed ID: 3242854
    [No Abstract]   [Full Text] [Related]  

  • 39. [Electrophysiologic effects of anti-arrhythmia agents. Their predictive value of therapeutic effects].
    Lévy S
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():29-35. PubMed ID: 6803700
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mechanisms of cellular action of anti-arrhythmia agents].
    Sebag C; Motté G
    Coeur Med Interne; 1978; 17(4):508-19. PubMed ID: 737994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.